ervebo vaccine

The US Food and Drug Administration (FDA) for the first time approved the Ebola virus (EVD) vaccine for people 18 years of age and older.

The European Pharmaceutical Commission has approved the circulation of the world's first Ervebo vaccine (rVSV -G-ZEBOV-GP) to prevent Ebola.